METASTATIC PROSTATE CANCER
Clinical trials for METASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive drug trial offers new hope for men with Tough-to-Treat prostate cancer
Disease control CompletedThis study tested whether adding a radioactive drug (I-131-1095) to standard medication (enzalutamide) could better control advanced prostate cancer that had worsened on a prior drug (abiraterone). It involved 120 men whose cancer had spread and was visible on a special PSMA scan…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Progenics Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Six-Month shot tested to control advanced prostate cancer
Disease control CompletedThis study tested a long-acting, 6-month injection (triptorelin) for Chinese men with advanced prostate cancer that has spread or is locally advanced. The main goal was to see if a single injection could safely and effectively lower testosterone to very low levels, which helps co…
Matched conditions: METASTATIC PROSTATE CANCER
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC